Dystonia may affect different areas of the body, and different neurological conditions cause different patterns of dystonia. Some occur only with a specific action, such as typing. Symptoms may worsen ...

Add Yahoo as a preferred source to see more of our stories on Google. When we think of movement disorders, the tremors associated with Parkinson’s disease are probably what first spring to mind.

Sodium oxybate provided temporary relief for laryngeal dystonia patients who were alcohol-responsive. The neurologic disorder causes laryngeal muscle spasms, leading to a chronically strained voice.

SAN ANTONIO, Texas (IvanhoeNewswire) – People with a disorder called dystonia experience involuntary muscle contractions, causing painful contortions and limiting movement. Surgeons have a simple ...

Oct. 14 (UPI) --A new award will help early career researchers who study dystonia, the Michael J. Fox Foundation announced Tuesday. The new Bachmann-Strauss Early Career Award is a two-year, $150,000 ...

The UAB Department of Neurology has established a new procedure clinic at Cooper Green Mercy Health to expand access to botulinum toxin therapy for issues like migraines, cervical dystonia, and other ...

Jonathan Allen first picked up the trombone in the fourth grade. After playing for years, he eventually earned a doctorate in musical arts and a teaching position at the University of Iowa. Then, one ...

Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or Parkinson's disease regain control of movement.

Sodium oxybate is the first oral treatment for laryngeal dystonia to show efficacy at providing temporary relief for debilitating symptoms that impact speaking, according to the results of a Mass Eye ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for ...

New $40 million raise brings Series A total to $100M, enabling advancement of VIM0423, a first-in-class oral therapeutic, into Phase 2 trials for isolated dystonia and for Parkinson’s diseaseFirst ...